FDA Approved: CAFERGOT — Supplemental Application (Trifluent Pharma, LLC)

View source ↗

Summary

FDA approved a supplemental application for CAFERGOT, a migraine treatment containing ergotamine tartrate and caffeine, submitted by Trifluent Pharma, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• CAFERGOT (ergotamine tartrate and caffeine)

Snippet

SUPPL AP for CAFERGOT (ERGOTAMINE TARTRATE AND CAFFEINE)